NCT00489346View on ClinicalTrials.gov

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

PHASE3CompletedINTERVENTIONAL
Enrollment

994

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Asthma, Bronchial
Interventions
DRUG

MK0476, montelukast sodium / Duration of Treatment: 1 Year

DRUG

Comparator : fluticasone propionate / Duration of Treatment: 1 Year

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00489346 - A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910) | Biotech Hunter | Biotech Hunter